News
6d
MoneyWeek on MSNFat profits: should you invest in weight-loss drugs?Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...
LUND, SWEDEN / ACCESS Newswire / April 29, 2025 / The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) resolved to re-elect the Board members Natalie ...
Halozyme Therapeutics, Inc. ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the BofA Securities 2025 Healthcare ...
President Trump’s proposed 25% tariff on pharmaceutical imports, largely from Ireland, could raise U.S. drug costs by nearly ...
TR: I have over thirty years of national and international experience in ... Technology cooperation with global pharmaceutical companies not only stimulates growth in manufacturing, R&,D ...
LUND, SWEDEN / ACCESS Newswire / April 29, 2025 / The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) resolved to re-elect the Board members Natalie ...
SDOG offers high-yield large-cap stocks with 4% dividends, sector diversification, and value pricing. Read why SDOG is a ...
Similarly it is expected that by 2015 four emerging market countries such as China, Brazil, India and Russia will be in the top ten ... pharmaceutical firms while tapping Chinese companies for ...
Germany plans to increase public investments by €500 billion over the next ten years. A new report from the Danish trade union Dansk Metal says this could lead to nearly 9,500 new jobs in Denmark.The ...
22h
TipRanks on MSNNavamedic Expands Eroxon® Launch to Denmark, Addressing Men’s Health NeedsNavamedic ASA ( ($DE:N1A) ) has shared an update. Navamedic ASA has launched Eroxon®, an over-the-counter topical treatment for erectile ...
VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces that President and Group Chief Executive Officer, Cameron Reynolds, has issued a Shareholder Letter providing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results